Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Zenas BioPharma, Inc.

NASDAQ: ZBIO · Life Sciences · 4 alerts · CIK 1953926

Share price
$27.93Close, Nov 16
Market cap
$1.89B
Shares outstanding
67.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zenas BioPharma, Inc. filings on SEC EDGAR ↗

4:16 PM ET 8-K
Capital Raise

Zenas BioPharma Capital Raise

Zenas BioPharma filed a new prospectus supplement to increase its at-the-market (ATM) offering program capacity by $200 million. This replaces a prior supplement under which the company had already sold approximately $153.2 million in common stock, leaving $46.8 million unsold from the previous authorization.

Counterparty
Jefferies LLC
6:03 AM ET 8-K
Clinical Trial Data

Zenas BioPharma Clinical Trial Data

Zenas BioPharma announced new data from its Phase 3 INDIGO trial and open-label extension for obexelimab in patients with IgG4-related disease (IgG4-RD). The findings demonstrated sustained clinical activity with a 93% probability of remaining flare-free over 12 months and a significant reduction in cumulative glucocorticoid toxicity compared to placebo.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.